Season 2—Are We There Yet?
How can companies create emotional brand experiences when traditional advertising methods are losing effectiveness? Experiential marketing engages consumers directly in brand experiences like live events and product rollouts, and is gaining traction as an effective way to generate a positive connection with a brand. A study revealed that 40% of consumers feel more brand…
Latest
Are We There Yet?
Phantom Auto | Remote Operation for Logistics Vehicles, Are We There Yet?
Remote operation for logistics vehicles sounds like a futuristic dream, but when dreams become reality, the future quickly morphs into the present. The logistics industry is undergoing a seismic shift thanks to groundbreaking technologies like remote operation for logistics vehicles. Phantom Auto, a leader in this space, is at the forefront of this transformation….
Are We There Yet?
Are We There Yet? | Blue Hawaiian Helicopters and Activities
As travel and tourism evolve, unique experiences like helicopter tours have become more than just adventures; they’re integral to the fabric of destination storytelling. In Hawaii, a place synonymous with natural beauty and the aloha spirit, helicopter tours offer unparalleled views and emotional connections to the landscape. Amidst this backdrop, Blue Hawaiian Helicopters &…
Are We There Yet?
Are We There Yet? | Cisco
In the transportation/mobility space, reliance on connectivity and security is critical to ensure reliability and safety, making conversations about how technology is reshaping transportation more relevant than ever. As the industry looks towards a future where vehicles are not just modes of transport but sophisticated nodes in a broader network of connectivity and security,…
Are We There Yet?
Instant Delivery Technology Unleashed: Ben James Reveals Game-Changing Logistics on ‘Are We There Yet?’
In an era where instant delivery technology has become the norm, the race to further accelerate the pace of receiving goods is on. The concept of getting products almost immediately after ordering is no longer a fantasy but a potential reality, thanks to groundbreaking advancements in logistics technology. With consumers and businesses alike craving…
Are We There Yet?
Automotive Hall of Fame: The “Untold Stories” of the Automotive Industry’s Trailblazers
In a rapidly evolving automotive landscape, reminiscing the past and honoring the industry’s pioneers pays tribute and draws inspiration for the future. The Automotive Hall of Fame, nestled in Dearborn, Michigan, is a testament to this ethos, encapsulating the chronicles of individuals who propelled the motor vehicle industry forward. With the automotive sector at…
Are We There Yet?
Inforum MobilityNext | 19TH Automotive Breakfast
The automotive industry is at the cusp of a revolutionary transformation, transitioning from the traditional automotive industry to a more extensive idea of mobility. This shift brings an air of exhilaration and anticipation, especially as witnessed within the recent 19th Automotive Breakfast in downtown Detroit, Michigan, a part of Inforum’s MobilityNEXT industry group’s exciting…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
